GREGORY SAMBUCHI: Open Payments
NPI 1942203112 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 53 payments from 24 companies in 2025. Trend: 2023 $2,221 · 2024 $1,473 · 2025 $1,244
Food & beverage: $1,185Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $215 |
| Averitas Pharma Inc. | 4 | $202 |
| Amgen Inc. | 5 | $117 |
| PFIZER INC. | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 2 | $77 |
| Eisai Inc. | 3 | $67 |
| SK Life Science, Inc. | 2 | $55 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Tanabe Pharma America, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $34 |
Products named: QUTENZA, BOTOX, UPLIZNA, NURTEC ODT, Leqembi, INGREZZA, Radicava, VYEPTI.
Industry payments across NY — which companies pay providers there.
